Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hyperplasia

• Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
• Treatment of BPH With CO2 Serenoa +PEA as Monotherapy or in Combination With Tamsulosin: ProSeRePEA Trial
• Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
• Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium
• Effects of TNF Blockade on Human BPH/LUTS
• Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
• Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia
• A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
• A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia
• Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
• Comparison Between Tamsulosin and Tadalafil in Management of Benign Prostatic Hyperplasia Long Term Study
• Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
• Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
• Study of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
• The Efficacy and Safety of Silodosin Singly or Combined With Ningmitai Capsules in the Treatment of Benign Prostatic Hyperplasia
• Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia
• Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB
• A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore
• 18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy
• Deprescribing Tamsulosin in Older Men
• The Combined Effect of Intravesical Botox Injections and HoLEP Surgery in Treating Benign Prostatic Hyperplasia and Overactive Bladder
• First-in-human Evaluation of [18F]CETO
• GnRHa + Letrozole vs Diane-35 + Metformin in Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
• Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
• Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia
• Longitudinal Follow-up in Women With Endometrial Hyperplasia Without Atypia
• Role of Prophylactic Postoperative Antibiotics in HoLEP
• (Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia
• Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia
• A Phase 2 Study to Evaluate the Safety, PK, and Exploratory PD of Tildacerfont in Children With CAH
• Intermittent Catheterization Versus Trial Without Catheter
• Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
• Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH
• Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
• Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia
• Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.
• The Effect of Pre-operative Use of Finasteride Versus Cyproterone Acetate on Blood Loss With Transurethral Resection of Prostate
• REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
• Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
• Clinical Trial of Ruxian Zengsheng No. 1 Decoction
• Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia
• Inhaled Treatment for Bronchopulmonary Dysplasia
• Metformin Plus Megestrol Acetate as a Fertility-sparing Treatment in Patients With Atypical Endometrial Hyperplasia
• Evaluation of the Effect of Garcinia in Combination With Chromium on the Clinical Outcomes of Patients With LUTS/BPH
• Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic Artery Embolization for Benign Prostatic Hyperplasia
• Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer
• Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ
• A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH
• Comparisons of Different Forms of Glucocorticoid on the Recovery of Reproductive Function in Patients With 21α-hydroxylase Deficiency
• Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia
• Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
• A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.
• A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH
• Anti-Androgen Treatment for COVID-19
• LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia
• 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
• Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH
• Ga-68 MAA Distribution in PAE Patients
• A Study of Xiangjurupining Capsule in the Treatment of Hyperplasia of Breast (Liver Stagnation and Phlegm Coagulation)
• Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)
• Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia
• Calcium Channel Blockade in Primary Aldosteronism
• A Pumpkin Seed, Isoflavonoid and Cranberry Mix in LUTS/BPH
• A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)
• Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)
• Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Pediatric Subjects With Congenital Adrenal Hyperplasia
• Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH)
• Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia
• Use of Melatonin for Preventing POCD in Transurethral Prostate Resection Under Spinal Anesthesia
• Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)
• Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal
• Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers
• Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia
• Benign Prostatic Hyperplasia and Ischemic Heart DIsease
• The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy
• The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia
• Clinical Study of Weifuchun Treatment on Precancerous Lesions of Gastric Cancer
• Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment
• Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia
• Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
• MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia
• Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
• Nevanimibe HCl for the Treatment of Classic CAH
• Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)
• Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia
• Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study
• Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia
• Androgen Reduction in Congenital Adrenal Hyperplasia
• Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia
• Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.
• Minimizing Narcotic Analgesics After Endocrine Surgery
• Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
• Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter
• Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer
• Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
• Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
• A Study to Evaluate the Efficacy and Safety of Radion™-Pdt in Patients With Oral Precancerous Lesion
• Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia
• Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia
• Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil
• Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer
• Surgicel® & Endometrial Ablation in the Management of Perimenpausal Heavy Menstrual Bleeding
• Prostatic Hyperplasia Treatment and Cancer Prevention
• A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH
• Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients
• Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
• An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone
• Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm Neonates
• Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH
• Ruxolitinib for Premalignant Breast Disease
• Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia
• Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia
• The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction
• A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH
• A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects
• Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia
• A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
• Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
• Superb Microvascular Imaging in Focal Nodular Hyperplasia
• Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia
• PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers
• Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms
• Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers
• A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules
• Study to Compare the Safety and Pharmacokinetics of CKD-397
• Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
• EC905 Pharmacokinetic Profile Study
• Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin
• Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
• Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects
• Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1
• Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients.
• Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
• The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.
• Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers
• A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).
• A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy
• Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.
• Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.
• Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer
• A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH
• TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST
• Safety and Pharmacokinetic Characteristics of DKF-313
• Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
• The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy
• A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
• Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS
• Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.
• Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms
• Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
• The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)
• Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia
• Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)
• Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms
• Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)
• Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)
• Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)
• Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade
• FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)
• Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia
• FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia
• Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia
• Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients
• Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin
• Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia
• Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States
• Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin
• A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation
• PERmixon® in LUTS Evaluation Study (PERLES)
• Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
• Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia
• Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia
• Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia
• Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration
• A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia
• Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
• The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia
• Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma
• Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction
• Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH
• This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study
• Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer
• Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride
• Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
• A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)
• Prostate Embolization for Benign Prostatic Hyperplasia
• Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
• Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
• The Effective Concentration of Lidocaine With Fentanyl in Lumbar Epidural Anesthesia for Transurethral Resection of Prostate(TURP) in Elderly Patients
• Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy.
• Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia
• Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)
• JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
• PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination
• TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE
• Clinical Management of Childhood Intestinal Lymphoid Nodular Hyperplasia
• Prospective Sexual Function Study for BPH Subjects
• Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
• Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia
• Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia
• Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)
• Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients
• Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH
• Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression
• Improving the Treatment for Women With Early Stage Cancer of the Uterus
• Metformin for the Treatment of Endometrial Hyperplasia
• Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels
• Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration
• Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
• Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study
• Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV
• Bioequivalence - Duodart Against Avodart & Omnic
• Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia)
• Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS
• Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects
• Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy
• Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)
• BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)
• Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women
• A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in
• Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.
• Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)
• Effects of Paclitaxel on Intimal Hyperplasia
• Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)
• Tocilizumab for KSHV-Associated Multicentric Castleman Disease
• Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
• Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy
• Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)
• Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence
• Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment
• Evaluation of a Low-Cost High Resolution Microendoscope for the Detection of Lower Gastrointestinal Neoplasia
• Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database
• Drug Use Investigation for AVOLVE(BPH)
• Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database
• Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD)
• Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial
• Bioequivalence Study of Tansulosine 0,4 mg Capsule in Health Subjects -Fed State
• Economic Analyses of the REDUCE Trial
• Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia
• Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia
• Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use
• SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin
• Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan
• Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)
• AVODART(Dutasteride) Post-marketing Surveillance(PMS)
• Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement
• A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy
• SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin
• Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)
• A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-
• A Comparative Study of KSO-0400 in BPH Patients With LUTS
• Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS
• A Study of Tadalafil in Benign Prostatic Hyperplasia
• A Study in Benign Prostatic Hyperplasia
• A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx
• A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
• Intravenous Tranexamic Acid and Intraoperative Visualization During Functional Endoscopic Sinus Surgery
• Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia
• Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
• A Study in Men With Benign Prostatic Hyperplasia
• A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia
• Single Ascending Dose (BMS-813160) Study
• Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia
• Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
• Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia
• Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms
• Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual Dysfunctions
• Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms
• A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)
• Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms
• MCS in the Treatment of Lower Urinary Tract Symptoms
• Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms
• Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)
• A Study of Tadalafil in Men With Benign Prostatic Hyperplasia
• Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia
• Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1
• Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
• Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg
• A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)
• Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
• Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
• Benign Prostatic Hyperplasia in Taiwan
• Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)
• Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants
• Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
• Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen
• Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
• Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
• A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia
• Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia
• Mirena Observational Program
• Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate
• Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia
• Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia
• A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia
• A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers
• Evaluation of Symptom-specific Goal Achievement
• Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction
• Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily
• A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031
• A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia
• Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension
• Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia
• Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)
• Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)
• Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants
• Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia
• Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
• Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
• A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart
• The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia
• Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker
• Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women
• Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia
• A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)
• Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement
• A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin
• Once Daily Given Alfuzosin in the Treatment of BPH
• A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
• PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates
• Dexamethasone Treatment of Congenital Adrenal Hyperplasia
• A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.
• Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia
• On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)
• Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up
• Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up
• Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems
• The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score
• Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men
• A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State
• Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia
• Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)
• Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.
• Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia
• Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS
• A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH
• Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
• MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia
• The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients
• SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
• Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate
• Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.
• ALF-STONE: Alfuzosin in Uretheric Stones
• Genistein and Endometrial Hyperplasia
• Botulinum Toxin Injection for the Management of BPH
• Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone
• Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
• A Clinical Trial Comparing Laser TURP With and Without Dutasteride.
• Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study
• Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter
• A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease
• Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia
• Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms
• Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
• Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia
• Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
• Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
• Study of the Effects of Pomegranate Tablets on Enlarged Prostates
• A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.
• Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer
• Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects
• Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease
• Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH
• Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH
• Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)
• ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH
• Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia
• ALF-ONE : ALFuzosin ONcE Daily
• Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)
• Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women
• Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
• The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months
• A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
• A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
• TRADE-Testosterone Replacement and Dutasteride Effectiveness
• Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)
• Effects of Pioglitazone in Congenital Adrenal Hyperplasia
• Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH)
• Kinetics of the Finasteride Prostate Induced Apoptosis
• Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
• A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)
• Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment
• Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis
• Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia
• Minimally Invasive Surgical Therapy for BPH
• Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels
• A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
• Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures
• Saw Palmetto Extract in Benign Prostatic Hyperplasia
• Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)
• Clinical Trial in Males With BPH (Enlarged Prostate)
• Medical Therapy of Prostatic Symptoms
• LY353381 in Preventing Breast Cancer in Women With Hyperplasia
• Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
• Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia
• A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
• Soy Estrogen Alternative Study (SEA)
• Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets